BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37692077)

  • 1. Self-sampling and HPV DNA testing for cervical precancer screening in a cohort of nuns in Ghana: a cross-sectional cohort study.
    Effah K; Tekpor E; Amuah JE; Essel NOM; Kemawor S; Catherine Morkli EA; Lamptey-Mills E; Wormenor CM; Manu LS; Klutsey GB; Danyo S; Akakpo PK
    EClinicalMedicine; 2023 Sep; 63():102183. PubMed ID: 37692077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
    Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
    Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of high-risk human papillomavirus infection and cervical lesions among female migrant head porters (kayayei) in Accra, Ghana: a pilot cross-sectional study.
    Tekpor E; Effah K; Sifa J; Amuah JE; Essel NOM; Kemawor S; Wormenor CM; Sesenu E; Danyo S; Akakpo PK
    BMC Public Health; 2024 Mar; 24(1):659. PubMed ID: 38429784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana.
    Dei-Adomakoh Y; Effah K; Tekpor E; Crabbe S; Amuah JE; Wormenor CM; Tay G; Asare EV; Kemawor S; Danyo S; Morkli EAC; Tibu F; Essel NO; Akakpo PK
    Ecancermedicalscience; 2023; 17():1571. PubMed ID: 37533951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the prevalence of high-risk human papillomavirus infection using a novel cervical precancer screening approach in incarcerated women at the Nsawam Medium Security Prison, Ghana.
    Acheampong LK; Effah K; Amuah JE; Tekpor E; Wormenor CM; Gedzah I; Kemawor S; Kachana AC; Danso PA; Essel NOM; Asomaning M; Agyiri D; Akakpo PK
    Ecancermedicalscience; 2021; 15():1248. PubMed ID: 34267804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
    Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
    BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tritesting in Battor, Ghana: an integrated cervical precancer screening strategy to mitigate the challenges of multiple screening visits and loss to follow-up.
    Effah K; Tekpor E; Wormenor CM; Essel NOM; Kemawor S; Sesenu E; Danyo S; Kitcher YT; Klutsey GB; Tay G; Tibu F; Abankroh KA; Atuguba BH; Akakpo PK
    Ecancermedicalscience; 2023; 17():1645. PubMed ID: 38414966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana.
    Effah K; Tekpor E; Wormenor CM; Amuah JE; Essel NO; Atuguba BH; Klutsey GB; Sesenu E; Tay G; Tibu F; Kemawor S; Gedzah I; Morkli EAC; Danyo S; Akakpo PK
    PLOS Glob Public Health; 2023; 3(4):e0001830. PubMed ID: 37079498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anal dysplasia screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Fast Transfer Analysis Cartridges for Cervical Sampling and Real Time PCR Based High Risk HPV Testing in Cervical Cancer Prevention - a Feasibility Study from South India.
    Vijayalakshmi R; Viveka TS; Malliga JS; Murugan K; Kanchana A; Arvind K
    Asian Pac J Cancer Prev; 2015; 16(14):5993-9. PubMed ID: 26320486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
    Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
    Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics.
    Ducancelle A; Reiser J; Pivert A; Le Guillou-Guillemette H; Le Duc-Banaszuk AS; Lunel-Fabiani F
    J Infect; 2015 Sep; 71(3):377-84. PubMed ID: 25964233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    Chaw L; Lee SHF; Ja'afar NIH; Lim E; Sharbawi R
    PLoS One; 2022; 17(3):e0262213. PubMed ID: 35287163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
    Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
    BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal and postnatal cervical precancer screening to increase coverage: experience from Battor, Ghana.
    Effah K; Tekpor E; Klutsey GB; Bannor HT; Amuah JE; Wormenor CM; Kemawor S; Danyo S; Atuguba BH; Manu LS; Essel NOM; Akakpo PK
    Ecancermedicalscience; 2023; 17():1616. PubMed ID: 38414944
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.